Exploring ADHD Symptoms and Associated Impairment across Development.
ADHD
ALSPAC
adult
impairment
longitudinal
prospective
Journal
Journal of attention disorders
ISSN: 1557-1246
Titre abrégé: J Atten Disord
Pays: United States
ID NLM: 9615686
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
pubmed:
25
6
2021
medline:
22
3
2022
entrez:
24
6
2021
Statut:
ppublish
Résumé
ADHD symptoms typically decline with age, but less is known about whether the presentation of specific ADHD symptoms differs across development. This study aimed to examine the frequency and associated impairment of specific ADHD symptoms in childhood, adolescence, and young adulthood. A prospective, longitudinal cohort, the Avon Longitudinal Study of Parents and Children, was utilized ( Specific ADHD symptom frequencies and their associated impairment varied across development for the majority of symptoms, although These findings suggest differences in the presentations of ADHD symptoms across development: current understanding of how ADHD presents in childhood/adolescence may not be generalizable to young adulthood.
Identifiants
pubmed: 34166143
doi: 10.1177/10870547211025612
pmc: PMC7612406
mid: EMS128746
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
822-830Subventions
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204895
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204895/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/3
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 217065/Z/19/Z
Pays : United Kingdom
Références
Atten Defic Hyperact Disord. 2017 Jun;9(2):73-88
pubmed: 27614892
BMC Med. 2020 May 25;18(1):146
pubmed: 32448170
J Atten Disord. 2016 Jan;20(1):11-20
pubmed: 24994874
J Atten Disord. 2012 Jul;16(5 Suppl):20S-38S
pubmed: 22377849
Mol Psychiatry. 2020 Aug;25(8):1631-1639
pubmed: 31959848
Psychiatry Res. 2019 Apr;274:75-90
pubmed: 30780065
Int J Epidemiol. 2018 Aug 1;47(4):1207-1216
pubmed: 29800128
J Child Psychol Psychiatry. 2011 Sep;52(9):954-63
pubmed: 21434915
J Child Psychol Psychiatry. 2021 Apr;62(4):449-457
pubmed: 32663329
Curr Psychiatry Rep. 2016 Dec;18(12):111
pubmed: 27783340
J Child Psychol Psychiatry. 2000 Jul;41(5):645-55
pubmed: 10946756
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Stat Methods Med Res. 2013 Jun;22(3):278-95
pubmed: 21220355
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
J Abnorm Psychol. 2002 May;111(2):279-89
pubmed: 12003449
Assessment. 2019 Oct;26(7):1234-1245
pubmed: 28758417
Psychol Med. 2006 Feb;36(2):159-65
pubmed: 16420712
J Am Acad Child Adolesc Psychiatry. 2008 Jan;47(1):76-85
pubmed: 18174828
J Child Psychol Psychiatry. 2015 Mar;56(3):345-65
pubmed: 25649325
J Clin Child Adolesc Psychol. 2010;39(6):761-75
pubmed: 21058124
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
Child Psychiatry Hum Dev. 2017 Jun;48(3):385-392
pubmed: 27363421
Lancet. 2016 Mar 19;387(10024):1240-50
pubmed: 26386541
J Abnorm Child Psychol. 2015 Oct;43(7):1243-55
pubmed: 25899878
Soc Psychiatry Psychiatr Epidemiol. 2011 Jun;46(6):521-32
pubmed: 20376427
Soc Psychiatry Psychiatr Epidemiol. 2007 Apr;42(4):322-7
pubmed: 17334898
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Wellcome Open Res. 2019 Mar 14;4:51
pubmed: 31020050
Psychol Assess. 2015 Mar;27(1):239-48
pubmed: 25222436
Neuropsychopharmacology. 2020 Sep;45(10):1617-1626
pubmed: 32279069